Evidence-Based Oncology™
About the Journal
Mission: Evidence-Based Oncology (EBO) is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care. EBO’s mission is to publish research and commentaries relevant to clinical decision makers and policy makers as they work to promote the efficient delivery of high-quality cancer care.
Readership: Evidence-Based Oncology™ circulates to nearly 20,500 individuals with important decision-making responsibilities who influence the access to and utilization of health care resources. Our audience includes medical directors, Medicaid directors, pharmacy and therapeutics committee members, pharmacy directors, formulary directors, physicians, corporate benefits managers, and other healthcare professionals across these 6 market segments: (1) HMO/PPO/IHOs; (2) hospitals; (3) long-term care; (4) PBMs; (5) VA/government; and (6) employers.
